Animal health company Elanco (NYSE:ELAN) will be reporting results this Wednesday before the bell. Here’s what investors ...

Elanco Animal Health (ELAN) is back in focus after U.S. regulators granted Emergency Use Authorization for Negasunt Powder ...

Elanco Animal Health confirmed on April 27 that it received an emergency use authorization from the US Food and Drug ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the pharmaceuticals stocks, including Elanco (NYSE:ELAN ...

Elanco Animal Health has demonstrated strong organic growth, driven by innovative products, with shares rebounding 80%. Read ...

Animal health company Elanco (NYSE:ELAN) reported Q1 CY2025 results , but sales were flat year on year at $1.19 billion. The company’s full-year revenue guidance of $4.55 billion at the midpoint came ...

Elanco, a company committed to animal health, introduces the Pet Collection of anti-flea, dog-shaped furniture, spreading ...

Elanco Animal Health said Monday it has agreed to sell its aqua business to Merck Animal Health for $1.3 billion, a move that allows it to pay down some of its debt load and invest in new pipeline ...

The stock price of Elanco (NYSE: ELAN), an animal health products company, saw a 20% fall on Thursday, June 27, after the company announced a delay in expected approval of two drugs. In comparison, ...

Elanco Animal Health Inc. announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug ...

To accelerate its debt repayments, Greenfield-based Elanco Animal Health on Monday announced the $295 million cash sale of future U.S. royalty and milestone rights of flea and tick treatment lotilaner ...

Elanco’s new headquarters on the west edge of downtown is scheduled to open early next year. (IBJ photo/Mickey Shuey) Ancora Holdings Inc. might be the scrappiest investment firm you’ve never heard of ...